mirtazapine has been researched along with Combat Disorders in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Combat Disorders: Neurotic reactions to unusual, severe, or overwhelming military stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Posttraumatic stress disorder (PTSD) is common among war veterans." | 1.35 | An open-label study of mirtazapine as treatment for combat-related PTSD. ( Alderman, CP; Condon, JT; Gilbert, AL, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alderman, CP | 1 |
| Condon, JT | 1 |
| Gilbert, AL | 1 |
1 other study available for mirtazapine and Combat Disorders
| Article | Year |
|---|---|
An open-label study of mirtazapine as treatment for combat-related PTSD.
Topics: Antidepressive Agents, Tricyclic; Australia; Combat Disorders; Dose-Response Relationship, Drug; Hum | 2009 |